{"hands_on_practices": [{"introduction": "The most fundamental kinetic advantage of metabolic channeling is its ability to control the fate of reactive or toxic intermediates. In this first practice ([@problem_id:2766169]), you will build a mathematical model to quantify this effect in a simple two-enzyme pathway. By deriving the relationship between the channeling efficiency and the concentration of a free intermediate, you will uncover a core principle guiding the design of synthetic metabolic systems.", "problem": "A two-enzyme pathway converts substrate $S$ to a final product $P$ via a toxic intermediate $I$. Enzyme $E_{1}$ produces $I$ from $S$ at a constant, zero-order rate $v_{1}$ (units of concentration per time) because $S$ is saturating. Enzyme $E_{2}$ consumes $I$ to form $P$ and, for freely diffusing $I$, follows Michaelis-Menten kinetics with maximum velocity $V_{\\max}$ and Michaelis constant $K_{m}$. A synthetic protein scaffold mediates substrate channeling such that a fraction $\\phi$ of the $I$ molecules produced by $E_{1}$ are directly delivered to the active site of $E_{2}$ without entering the freely diffusing pool; the remaining fraction $(1-\\phi)$ enters the freely diffusing pool. Assume that $0 \\leq \\phi \\leq 1$ and that the overall steady-state is feasible, i.e., $v_{1} < V_{\\max}$.\n\nThe channeled and freely diffusing substrates compete for the same catalytic capacity of $E_{2}$, which cannot exceed $V_{\\max}$ in total. Treat the freely diffusing pool of $I$ as a well-mixed compartment and use steady-state mass balance for that pool. From first principles, derive the steady-state concentration $[I]_{\\text{free}}(\\phi)$ of freely diffusing $I$ as a function of $v_{1}$, $V_{\\max}$, $K_{m}$, and $\\phi$. Then, define the fractional reduction in freely diffusing $I$ due to channeling as\n$$\nr \\equiv 1 - \\frac{[I]_{\\text{free}}(\\phi)}{[I]_{\\text{free}}(0)} \\, .\n$$\nProvide a closed-form analytic expression for $r$ in terms of $v_{1}$, $V_{\\max}$, $K_{m}$, and $\\phi$. Your final answer must be a single expression. No numerical evaluation is required.", "solution": "The problem statement has been analyzed and is deemed valid. It is scientifically grounded in established principles of enzyme kinetics and metabolic modeling, is well-posed with sufficient and consistent information, and is formulated with objective, precise language. There are no identifiable flaws. We may therefore proceed with the derivation.\n\nThe core of this problem is a steady-state mass balance on the concentration of the freely diffusing intermediate, denoted as $[I]_{\\text{free}}$. At steady state, the rate of influx of $I$ into the free pool must equal the rate of its efflux or consumption from that pool.\n\nFirst, we define the rate of influx. The enzyme $E_{1}$ produces the intermediate $I$ at a constant total rate of $v_{1}$. A fraction $(1-\\phi)$ of this production enters the freely diffusing pool. Therefore, the rate of influx is:\n$$ \\text{Rate of Influx} = (1-\\phi) v_{1} $$\n\nNext, we must derive the rate of efflux, which is the rate of consumption of the freely diffusing intermediate by enzyme $E_{2}$, denoted as $v_{\\text{free}}$. The problem states that the channeled and free substrates compete for the catalytic capacity of $E_{2}$. We must derive the kinetic law for $v_{\\text{free}}$ from first principles.\n\nLet $[E_t]$ be the total concentration of enzyme $E_{2}$. The maximum possible velocity is $V_{\\max} = k_{cat} [E_t]$, where $k_{cat}$ is the turnover number.\nThe total rate of consumption of $I$ by $E_2$ (both channeled and free) must equal the total rate of production of $I$ at steady-state for the whole system, which is $v_{1}$.\nThe fraction of the total enzyme population that is catalytically active (i.e., in an enzyme-substrate complex) is given by the ratio of the actual total velocity to the maximum velocity, which is $v_{1}/V_{\\max}$.\nThe fraction of enzyme that is in the free, unbound state, $[E]$, is therefore:\n$$ \\frac{[E]}{[E_t]} = 1 - \\frac{v_{1}}{V_{\\max}} $$\nThus, the concentration of free enzyme is:\n$$ [E] = [E_t] \\left( 1 - \\frac{v_{1}}{V_{\\max}} \\right) $$\nThe consumption of the freely diffusing substrate, $[I]_{\\text{free}}$, proceeds via the formation of the enzyme-substrate complex, $[ES_{\\text{free}}]$. The steady-state assumption for this complex is:\n$$ k_{1} [E] [I]_{\\text{free}} = (k_{-1} + k_{cat}) [ES_{\\text{free}}] $$\nwhere $k_{1}$ is the forward binding rate constant and $k_{-1}$ is the reverse dissociation rate constant.\nRecalling the definition of the Michaelis constant, $K_{m} = \\frac{k_{-1} + k_{cat}}{k_{1}}$, we can write:\n$$ k_{1} [E] [I]_{\\text{free}} = k_{1} K_{m} [ES_{\\text{free}}] $$\n$$ [ES_{\\text{free}}] = \\frac{[E] [I]_{\\text{free}}}{K_{m}} $$\nNow, we substitute the expression for the free enzyme concentration $[E]$:\n$$ [ES_{\\text{free}}] = \\frac{[E_t] \\left( 1 - \\frac{v_{1}}{V_{\\max}} \\right) [I]_{\\text{free}}}{K_{m}} $$\nThe rate of consumption of the free substrate, $v_{\\text{free}}$, is given by $v_{\\text{free}} = k_{cat} [ES_{\\text{free}}]$. Substituting the expression for $[ES_{\\text{free}}]$:\n$$ v_{\\text{free}} = k_{cat} \\frac{[E_t] \\left( 1 - \\frac{v_{1}}{V_{\\max}} \\right) [I]_{\\text{free}}}{K_{m}} $$\nUsing $V_{\\max} = k_{cat} [E_t]$, this simplifies to:\n$$ v_{\\text{free}} = \\frac{V_{\\max} \\left( 1 - \\frac{v_{1}}{V_{\\max}} \\right) [I]_{\\text{free}}}{K_{m}} = \\frac{(V_{\\max} - v_{1}) [I]_{\\text{free}}}{K_{m}} $$\nThis derived kinetic law shows that under the load $v_1$, the consumption of the free substrate follows first-order kinetics with a rate constant of $\\frac{V_{\\max} - v_{1}}{K_{m}}$.\n\nNow we apply the steady-state condition for the free pool: Rate of Influx = Rate of Efflux.\n$$ (1-\\phi) v_{1} = \\frac{(V_{\\max} - v_{1})}{K_{m}} [I]_{\\text{free}}(\\phi) $$\nWe can now solve for the steady-state concentration of the free intermediate, $[I]_{\\text{free}}(\\phi)$:\n$$ [I]_{\\text{free}}(\\phi) = K_{m} \\frac{(1-\\phi) v_{1}}{V_{\\max} - v_{1}} $$\nThis expression is valid because the problem specifies that a steady state is feasible, meaning $v_{1} < V_{\\max}$, which ensures the denominator is positive.\n\nThe next step is to calculate the fractional reduction $r$, defined as $r \\equiv 1 - \\frac{[I]_{\\text{free}}(\\phi)}{[I]_{\\text{free}}(0)}$.\nFirst, we find $[I]_{\\text{free}}(0)$, which is the concentration in the absence of channeling ($\\phi=0$). We set $\\phi=0$ in our derived expression:\n$$ [I]_{\\text{free}}(0) = K_{m} \\frac{(1-0) v_{1}}{V_{\\max} - v_{1}} = K_{m} \\frac{v_{1}}{V_{\\max} - v_{1}} $$\nNow, we form the ratio:\n$$ \\frac{[I]_{\\text{free}}(\\phi)}{[I]_{\\text{free}}(0)} = \\frac{K_{m} \\frac{(1-\\phi) v_{1}}{V_{\\max} - v_{1}}}{K_{m} \\frac{v_{1}}{V_{\\max} - v_{1}}} $$\nThe terms $K_{m}$, $v_{1}$, and $(V_{\\max} - v_{1})$ cancel out, leaving:\n$$ \\frac{[I]_{\\text{free}}(\\phi)}{[I]_{\\text{free}}(0)} = 1 - \\phi $$\nFinally, we compute the fractional reduction $r$:\n$$ r = 1 - \\frac{[I]_{\\text{free}}(\\phi)}{[I]_{\\text{free}}(0)} = 1 - (1 - \\phi) = \\phi $$\nThe fractional reduction in the concentration of the toxic intermediate is simply equal to the fraction of metabolic flux that is channeled.", "answer": "$$ \\boxed{\\phi} $$", "id": "2766169"}, {"introduction": "Effective scaffold engineering bridges abstract kinetic models with concrete physical structures. This practice ([@problem_id:2766131]) challenges you to think like a structural bioengineer, using 3D coordinate data to assess a scaffold's geometric feasibility. By comparing the engineered distance between active sites to the intermediate's diffusion length, you will perform a critical \"back-of-the-envelope\" calculation to predict whether a design can successfully facilitate channeling.", "problem": "A two-enzyme pathway is engineered on a modular protein scaffold to promote metabolic channeling. Enzyme $E_1$ produces a short-lived intermediate $X$ that is consumed by enzyme $E_2$. Structural models (for example, X-ray structures in the Protein Data Bank (PDB) or AlphaFold predictions) are used to define each enzyme’s “active-site vector”: the unit vector from its scaffold attachment point toward its product-release (for $E_1$) or substrate-entry (for $E_2$) location. Assume the following scaffold geometry in a fixed Cartesian frame (all lengths in nanometers):\n- The attachment point of $E_1$ is at $\\mathbf{r}_1 = (0, 0, 0)$, and the unit “active-site vector” for $E_1$ is $\\mathbf{u}_1 = \\left(\\frac{1}{3}, \\frac{2}{3}, \\frac{2}{3}\\right)$. The product-release point of $E_1$ lies a distance $s_1 = 3.2$ along $\\mathbf{u}_1$ from $\\mathbf{r}_1$.\n- The attachment point of $E_2$ is at $\\mathbf{r}_2 = (8, 3, 0)$, and the unit “active-site vector” for $E_2$ is $\\mathbf{u}_2 = \\left(-\\frac{2}{3}, -\\frac{1}{3}, \\frac{2}{3}\\right)$. The substrate-entry point of $E_2$ lies a distance $s_2 = 2.8$ along $\\mathbf{u}_2$ from $\\mathbf{r}_2$.\n\nModel the intermediate $X$ as a point particle undergoing Brownian motion with diffusion coefficient $D_X$ and a competing first-order loss (e.g., hydrolysis or off-pathway reaction) with rate constant $k_{\\text{loss}}$. In reaction-diffusion with first-order decay, a natural “capture radius” for channeling is the diffusion length $L$ associated with the decay process, defined by the characteristic length scale over which the probability density decays from a point source. Use $D_X = 4.5 \\times 10^{-10}$ in $\\mathrm{m^2 \\, s^{-1}}$ and $k_{\\text{loss}} = 1.5 \\times 10^{7}$ in $\\mathrm{s^{-1}}$.\n\nUsing the given vectors and offsets, compute:\n1) the Euclidean distance $d$ between the $E_1$ product-release point and the $E_2$ substrate-entry point, and\n2) the diffusion length $L$ of the intermediate $X$ from first principles of diffusion with first-order decay.\n\nReport the quantitative “channeling margin” $\\Delta = L - d$ as a single number in nanometers. Round your result to four significant figures. Express the answer in $\\mathrm{nm}$.", "solution": "The problem statement is validated as scientifically grounded, mathematically well-posed, and free of ambiguity. It describes a standard biophysical model of metabolic channeling, with all necessary parameters provided for a unique solution. We shall proceed with the derivation.\n\nThe problem requires the calculation of two quantities: the geometric distance $d$ between the active sites, and the characteristic diffusion length $L$ of the intermediate species. The final answer is the \"channeling margin\" $\\Delta = L - d$.\n\nFirst, we determine the coordinates of the product-release point of enzyme $E_1$ and the substrate-entry point of enzyme $E_2$. Let these points be denoted by the position vectors $\\mathbf{p}_1$ and $\\mathbf{p}_2$, respectively.\n\nThe position vector $\\mathbf{p}_1$ is found by starting at the attachment point $\\mathbf{r}_1$ and moving along the direction of the active-site vector $\\mathbf{u}_1$ by a distance $s_1$.\n$$\n\\mathbf{p}_1 = \\mathbf{r}_1 + s_1 \\mathbf{u}_1\n$$\nSubstituting the given values:\n$$\n\\mathbf{p}_1 = (0, 0, 0) + 3.2 \\left(\\frac{1}{3}, \\frac{2}{3}, \\frac{2}{3}\\right) = \\left(\\frac{3.2}{3}, \\frac{6.4}{3}, \\frac{6.4}{3}\\right) \\, \\mathrm{nm}\n$$\nSimilarly, the position vector $\\mathbf{p}_2$ is found by starting at $\\mathbf{r}_2$ and moving along $\\mathbf{u}_2$ by a distance $s_2$.\n$$\n\\mathbf{p}_2 = \\mathbf{r}_2 + s_2 \\mathbf{u}_2\n$$\nSubstituting the given values:\n$$\n\\mathbf{p}_2 = (8, 3, 0) + 2.8 \\left(-\\frac{2}{3}, -\\frac{1}{3}, \\frac{2}{3}\\right) = \\left(8 - \\frac{5.6}{3}, 3 - \\frac{2.8}{3}, \\frac{5.6}{3}\\right) = \\left(\\frac{24 - 5.6}{3}, \\frac{9 - 2.8}{3}, \\frac{5.6}{3}\\right) = \\left(\\frac{18.4}{3}, \\frac{6.2}{3}, \\frac{5.6}{3}\\right) \\, \\mathrm{nm}\n$$\nThe Euclidean distance $d$ is the magnitude of the displacement vector between these two points, $\\Delta\\mathbf{p} = \\mathbf{p}_2 - \\mathbf{p}_1$.\n$$\n\\Delta\\mathbf{p} = \\left(\\frac{18.4 - 3.2}{3}, \\frac{6.2 - 6.4}{3}, \\frac{5.6 - 6.4}{3}\\right) = \\left(\\frac{15.2}{3}, -\\frac{0.2}{3}, -\\frac{0.8}{3}\\right) \\, \\mathrm{nm}\n$$\nThe distance $d$ is the norm of this vector:\n$$\nd = ||\\Delta\\mathbf{p}|| = \\sqrt{\\left(\\frac{15.2}{3}\\right)^2 + \\left(-\\frac{0.2}{3}\\right)^2 + \\left(-\\frac{0.8}{3}\\right)^2}\n$$\n$$\nd = \\frac{1}{3} \\sqrt{(15.2)^2 + (-0.2)^2 + (-0.8)^2} = \\frac{1}{3} \\sqrt{231.04 + 0.04 + 0.64} = \\frac{\\sqrt{231.72}}{3} \\, \\mathrm{nm}\n$$\nCalculating the numerical value:\n$$\nd \\approx \\frac{15.222352}{3} \\approx 5.074117 \\, \\mathrm{nm}\n$$\n\nNext, we calculate the diffusion length $L$. The problem describes a process of diffusion with a competing first-order loss reaction. The governing partial differential equation for the concentration of the intermediate, $C(\\mathbf{r}, t)$, is the reaction-diffusion equation:\n$$\n\\frac{\\partial C}{\\partial t} = D_X \\nabla^2 C - k_{\\text{loss}} C\n$$\nAt steady state, $\\frac{\\partial C}{\\partial t} = 0$, which simplifies the equation to:\n$$\nD_X \\nabla^2 C - k_{\\text{loss}} C = 0 \\quad \\implies \\quad \\nabla^2 C = \\frac{k_{\\text{loss}}}{D_X} C\n$$\nThe solutions to this equation exhibit exponential decay. The characteristic length scale of this decay, known as the diffusion length $L$, is defined by the relation $L^{-2} = k_{\\text{loss}} / D_X$. Therefore, the diffusion length $L$ is given by:\n$$\nL = \\sqrt{\\frac{D_X}{k_{\\text{loss}}}}\n$$\nWe substitute the provided values for the diffusion coefficient $D_X$ and the loss rate constant $k_{\\text{loss}}$. It is crucial to maintain dimensional consistency.\n$$\nD_X = 4.5 \\times 10^{-10} \\, \\mathrm{m^2 \\, s^{-1}}\n$$\n$$\nk_{\\text{loss}} = 1.5 \\times 10^{7} \\, \\mathrm{s^{-1}}\n$$\n$$\nL = \\sqrt{\\frac{4.5 \\times 10^{-10} \\, \\mathrm{m^2 \\, s^{-1}}}{1.5 \\times 10^{7} \\, \\mathrm{s^{-1}}}} = \\sqrt{3.0 \\times 10^{-17} \\, \\mathrm{m^2}}\n$$\nTo simplify the calculation and convert to nanometers, we rewrite the term under the square root:\n$$\nL = \\sqrt{30 \\times 10^{-18} \\, \\mathrm{m^2}} = \\sqrt{30} \\times 10^{-9} \\, \\mathrm{m}\n$$\nSince $1 \\, \\mathrm{nm} = 10^{-9} \\, \\mathrm{m}$, the diffusion length in nanometers is:\n$$\nL = \\sqrt{30} \\, \\mathrm{nm} \\approx 5.477226 \\, \\mathrm{nm}\n$$\nFinally, we compute the channeling margin $\\Delta$ as the difference between the diffusion length $L$ and the inter-site distance $d$.\n$$\n\\Delta = L - d\n$$\n$$\n\\Delta \\approx 5.477226 \\, \\mathrm{nm} - 5.074117 \\, \\mathrm{nm} \\approx 0.403109 \\, \\mathrm{nm}\n$$\nThe problem requires the result rounded to four significant figures.\n$$\n\\Delta \\approx 0.4031 \\, \\mathrm{nm}\n$$\nThis positive value for $\\Delta$ indicates that the characteristic diffusion length is greater than the geometric separation of the active sites, and thus metabolic channeling is plausible under this model.", "answer": "$$\n\\boxed{0.4031}\n$$", "id": "2766131"}, {"introduction": "In synthetic biology, a compelling hypothesis is only as strong as the experiments designed to test it. This final practice ([@problem_id:2766121]) shifts focus from calculation to experimental design, asking you to identify the most rigorous methods for falsifying a channeling claim. Learning to distinguish robust experimental strategies from those with confounding variables is a crucial skill for any research scientist.", "problem": "A three-enzyme pathway in a bacterium converts substrate $S$ to product $P$ via intermediates $I_1$ and $I_2$ through enzymes $E_1$, $E_2$, and $E_3$. A synthetic protein scaffold is suspected to organize $E_1$, $E_2$, and $E_3$ into a metabolon that channels $I_1$ and $I_2$. A colleague proposes that the observed elevated flux to $P$ arises solely from increased total enzyme abundance or altered catalytic turnover rather than channeling. You are tasked with designing an experiment that could falsify the hypothesis that the suspected metabolon exhibits channeling, by specifically disrupting protein-protein interactions while keeping enzyme expression and catalytic activities unchanged.\n\nUse the following foundational bases in your reasoning: mass conservation, Fick’s law of diffusion for small metabolites in cytosol, and Michaelis–Menten kinetics for enzyme turnover. In particular, define flux $J$ through the pathway as the steady-state rate of $P$ formation; assume that in the absence of channeling, $J$ depends on the bulk concentrations and kinetic parameters ($k_{\\mathrm{cat}}$, $K_M$) of each enzyme and that local protein-protein interactions do not alter $k_{\\mathrm{cat}}$ or $K_M$ when only interaction interfaces, not active sites, are perturbed. In contrast, if channeling exists, scaffold-mediated proximity yields an elevated effective capture probability of $I_1$ and $I_2$ by $E_2$ and $E_3$, respectively, beyond what is predicted by bulk diffusion and well-mixed kinetics.\n\nWhich of the following experimental designs and control strategies most rigorously attempts to falsify the channeling hypothesis under scientifically realistic conditions? Select all that apply.\n\nA. Engineer minimal point mutations in the short peptide ligands that recruit $E_1$, $E_2$, and $E_3$ to the scaffold (for example, proline-to-alanine in a proline-rich motif or a valine-to-aspartate swap in a PDZ-binding tail) that are predicted, by structure, to disrupt binding without perturbing the enzyme fold. Verify loss of binding affinity by equilibrium measurements (for example, isothermal titration calorimetry) showing an increase in dissociation constant $K_d$ and verify unchanged catalytic parameters by in vitro assays of $k_{\\mathrm{cat}}$ and $K_M$. Confirm equal intracellular abundance by quantitative targeted proteomics. Then, in vivo, measure steady-state flux $J$ and intermediate pool sizes using short-pulse $\\mathrm{^{13}C}$-substrate labeling and targeted mass spectrometry under matched growth conditions, with and without an acute addition of a cell-permeable competitor peptide that further displaces enzymes from the scaffold. Interpret an unchanged $J$ upon disrupting interactions (with $k_{\\mathrm{cat}}$, $K_M$, and abundance held constant) as evidence falsifying channeling.\n\nB. Overexpress catalytically dead variants of $E_2$ and $E_3$ that retain scaffold binding to compete with the wild-type enzymes for scaffold sites, and quantify the resulting reduction in $J$. Use the reduction in $J$ as evidence against channeling.\n\nC. Increase ionic strength by adding high salt to the medium to weaken transient interactions on the scaffold while simultaneously assaying $J$, and use any change in $J$ to evaluate channeling. Assume catalytic parameters and expression remain unchanged because enzymes are assayed in vivo.\n\nD. Delete the scaffold gene entirely, then reintroduce only $E_1$, $E_2$, and $E_3$ under the same promoters used previously. If $J$ remains similar between the deletion and wild-type strains, conclude that channeling is falsified.\n\nE. Introduce structure-guided, surface-exposed charge-reversal mutations at the predicted $E_1$–$E_2$ and $E_2$–$E_3$ protein-protein interfaces that specifically weaken binding (confirm by an increased $K_d$ measured by bio-layer interferometry) while leaving active-site residues intact. Demonstrate unchanged $k_{\\mathrm{cat}}$ and $K_M$ in vitro and equal intracellular abundance in vivo. Employ an orthogonal, inducible dimerization system (for example, a rapamycin analog-inducible FK506-binding protein–FKBP–rapamycin-binding domain pair fused at termini distal to active sites) to acutely restore proximity without altering expression or catalytic parameters. Compare $J$ and intermediate pool sizes across the interface-mutant, rescued, and wild-type conditions using short-pulse $\\mathrm{^{13}C}$ tracing. Interpret an unchanged $J$ in the interface-disrupted condition as falsifying channeling, and a selective rescue of $J$ upon inducible re-tethering as a control for off-target effects of the mutations.\n\nAnswer choices are independent; select all that are appropriate.", "solution": "The problem statement is scientifically sound, well-posed, and objective. It provides a clear theoretical framework based on established principles of enzyme kinetics, diffusion, and mass conservation to evaluate experimental designs in synthetic biology. All terms are well-defined, and the task is to assess the rigor of proposed experiments, which is a valid scientific question. No flaws are identified.\n\nThe central challenge in falsifying the channeling hypothesis is to experimentally isolate the effect of enzyme-enzyme proximity from two major confounding variables: the total intracellular abundance of the enzymes and their intrinsic catalytic parameters ($k_{\\mathrm{cat}}$ and $K_M$). A rigorous experiment must specifically perturb the protein-protein interactions responsible for forming the metabolon while demonstrating, not merely assuming, that enzyme concentrations and activities are unchanged. The flux $J$ through the pathway is the primary observable. According to the problem definition, if channeling is occurring, flux $J$ is enhanced by scaffold-mediated proximity. Therefore, to falsify channeling, one must show that disrupting this proximity, while all other factors are held constant, results in no significant change in $J$.\n\nLet us evaluate each option based on this principle.\n\n**Option A:** This experimental design proposes to introduce minimal point mutations into the peptide ligands that mediate enzyme-scaffold binding. The strategy is to disrupt these specific interactions. The rigor of this approach is established by a comprehensive set of controls:\n$1$. The disruption of binding is to be quantitatively verified by biophysical measurement (isothermal titration calorimetry, ITC) showing an increased dissociation constant, $K_d$. This directly confirms the perturbation was successful at the molecular level.\n$2$. The critical assumption that the mutations do not affect catalytic activity is to be tested by in vitro assays of $k_{\\mathrm{cat}}$ and $K_M$. This rules out changes in intrinsic enzyme efficiency as the cause of any observed flux change.\n$3$. The equally critical assumption of constant enzyme level is to be confirmed using quantitative targeted proteomics. This rules out changes in protein expression or stability.\n$4$. Flux $J$ and intermediate pools are to be measured in vivo using short-pulse $^{13}\\mathrm{C}$-substrate labeling, which is the state-of-the-art technique for such measurements.\nThe logic presented is correct: if, after confirmed disruption of interactions and with constant enzyme abundance and activity, the flux $J$ remains unchanged, this would constitute strong evidence against a functional role for channeling. The additional use of a competitor peptide provides a second, orthogonal method of disrupting the interactions in an acute manner, further strengthening the potential conclusion. This design is scientifically rigorous and directly addresses the core question.\nVerdict: **Correct**.\n\n**Option B:** This option proposes to overexpress catalytically dead variants of $E_2$ and $E_3$ to compete for scaffold binding sites. The stated logic is that a resulting reduction in flux $J$ would be \"evidence against channeling.\" This logic is fundamentally flawed. If channeling is significant, active enzymes $E_2$ and $E_3$ gain a kinetic advantage by being on the scaffold. Displacing them with inactive competitors would disrupt this channeled flux, leading to a *decrease* in $J$. Therefore, a reduction in $J$ would be evidence *for*, not against, the importance of scaffold-mediated organization. Furthermore, the experiment is confounded. The dead enzymes might still bind the intermediates, titrating them away from the active enzymes, which would reduce flux regardless of channeling. The experiment does not cleanly separate the effects of proximity from simple competitive inhibition for scaffold real estate or intermediate sequestration.\nVerdict: **Incorrect**.\n\n**Option C:** This option proposes using high salt concentration in the growth medium to weaken protein-protein interactions. The critical flaw is the assumption that \"catalytic parameters and expression remain unchanged because enzymes are assayed in vivo.\" This assumption is invalid and unscientific. High extracellular osmolarity induces a significant stress response in bacteria, leading to global changes in gene expression and protein synthesis. Furthermore, changes in intracellular ionic strength can directly impact the stability, folding, and catalytic activity of many enzymes. The perturbation is non-specific and has numerous pleiotropic effects. Any observed change in $J$ cannot be unambiguously attributed to the disruption of enzyme-scaffold interactions. This experimental design lacks the necessary specificity and controls.\nVerdict: **Incorrect**.\n\n**Option D:** This option suggests deleting the scaffold gene entirely and comparing the flux $J$ to the wild-type strain. While this directly removes the basis for scaffold-mediated channeling, it is a \"sledgehammer\" approach that lacks subtlety and rigorous controls. The assumption that reintroducing the enzymes under the same promoters will result in identical expression levels is naive. Gene expression is sensitive to chromosomal location, local topology, and regulatory context, all of which are altered in such a gene deletion/re-introduction strategy. The options A and E are superior because they propose to *measure* and *confirm* equal protein abundance in an isogenic background, rather than assuming it across different engineered strains. Moreover, this approach does not control for any potential secondary functions of the scaffold protein unrelated to channeling. While the intent is correct, the execution described is less rigorous than alternatives.\nVerdict: **Incorrect**.\n\n**Option E:** This design is similar to option A in its core strategy of using targeted mutations but adds a layer of exceptional rigor. It proposes structure-guided charge-reversal mutations at the specific protein-protein interfaces, a precise way to disrupt binding. Like option A, it includes the essential controls: verification of weakened binding (increased $K_d$ via bio-layer interferometry), unchanged catalytic parameters ($k_{\\mathrm{cat}}$, $K_M$), and equal intracellular abundance. The key addition is the \"rescue\" experiment. An orthogonal, inducible dimerization system is used to artificially re-tether the enzymes *after* their natural interaction has been broken by mutation. This provides a powerful control for off-target effects. If the flux $J$ decreases in the interface-mutant and is then restored upon induced dimerization, this provides definitive evidence that the flux phenotype is a direct consequence of enzyme proximity and not some unforeseen artifact of the mutations. The logic that an unchanged $J$ in the disrupted state falsifies channeling is correct, and the rescue component makes the entire design exceptionally robust.\nVerdict: **Correct**.\n\nIn summary, options A and E describe the most rigorous, specific, and well-controlled experimental designs to falsify the hypothesis of metabolic channeling. They correctly identify the need to isolate the variable of proximity and include the necessary biophysical and biochemical verifications to rule out confounding factors.", "answer": "$$\\boxed{AE}$$", "id": "2766121"}]}